Chugai's ¥7bn-plus quake losses drag down bottom line
This article was originally published in Scrip
Chugai has booked a total of ¥7.4 billion ($96.9 million) so far this year in extraordinary losses related to the devastating earthquake and tsunami in Japan, and expects the figure to rise to around ¥7.5 billion for the 12 months excluding any insurance payouts.
You may also be interested in...
Japan approval for BTK inhibitor marks new indication but in a small niche market, while another clearance may help extend Latuda's commercial life.
Novel antibody-drug conjugate receives approval in Japan for second-line breast cancer, providing another push to Japanese firm’s strategic plan to build up its oncology operations.
Collaboration with fundraising Tokyo-based venture builds mid-sized firm's interest in cell-based therapies in a highly supportive regulatory environment.